| RS2041984041 |
KANSL1
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2041988738 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS2041989919 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2041989992 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2041990527 |
PSMD12
|
Health Risk |
Pathogenic/Likely pathogenic |
Stankiewicz-Isidor syndrome, Stankiewicz-Isidor syndrome |
| RS2041992812 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2041993956 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2042010887 |
DMXL2
|
Health Risk |
Pathogenic |
— |
| RS2042021811 |
POLE
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2042023109 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042023669 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042024442 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042025444 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS2042069041 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2042070838 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2042079691 |
SLC12A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bartter syndrome, Bartter syndrome |
| RS2042109833 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2042123799 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2042124608 |
SYNJ1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 53 |
| RS2042128326 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2042135430 |
PIEZO2
|
Health Risk |
Likely pathogenic |
Arthrogryposis, distal |
| RS2042138847 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Thyroid cancer |
| RS2042144091 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042144519 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2042150698 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2042151724 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2042163217 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2042166568 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2042173919 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2042176558 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042181751 |
SETD5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2042188851 |
SETD5
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2042190198 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2042190375 |
SETD5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2042191502 |
SETD5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2042191795 |
SETD5
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2042193330 |
UNG
|
Health Risk |
Likely pathogenic |
Hyper-IgM syndrome type 5, Hyper-IgM syndrome type 5 |
| RS2042197714 |
SETD5
|
Health Risk |
Likely pathogenic |
Moyamoya angiopathy with developmental delay, Moyamoya angiopathy with developmental delay |
| RS2042198580 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042200333 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS2042205100 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042205289 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042206485 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2042210578 |
SETD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Luscan-Lumish syndrome, SETD2-related disorder |
| RS2042212599 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042215003 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042215726 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042216996 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042218001 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2042227620 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042252455 |
MYPN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1KK, Cardiovascular phenotype |
| RS2042262374 |
SETD5
|
Health Risk |
Pathogenic |
Cleft palate, Intellectual disability |
| RS2042266753 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2042271732 |
SETD5
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS2042301516 |
GRIN2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2042303226 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2042316930 |
NALCN
|
Health Risk |
Pathogenic |
— |
| RS2042342323 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS2042344677 |
SYNJ1
|
Health Risk |
Pathogenic |
— |
| RS2042349678 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042349830 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Intrauterine growth retardation |
| RS2042361612 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042362718 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042365082 |
NEDD4L
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2042376634 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042376718 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042378606 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2042379484 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2042382246 |
CNOT1
|
Health Risk |
Likely pathogenic |
Vissers-Bodmer syndrome, Vissers-Bodmer syndrome |
| RS2042382430 |
CNOT1
|
Health Risk |
Pathogenic |
Vissers-Bodmer syndrome, Vissers-Bodmer syndrome |
| RS2042382744 |
OCA2
|
Health Risk |
Likely pathogenic |
Tyrosinase-positive oculocutaneous albinism, Tyrosinase-positive oculocutaneous albinism |
| RS2042383988 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2042387354 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS2042417862 |
QARS1
|
Health Risk |
Likely pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS2042419194 |
DDC
|
Health Risk |
Pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS2042438780 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS2042442594 |
HDAC4
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe intellectual disability, Neurodevelopmental disorder with central hypotonia and dysmorphic facies |
| RS2042447540 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2042447850 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2042448519 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2042448930 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2042449005 |
GRIN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Landau-Kleffner syndrome |
| RS2042450868 |
GRIN2A
|
Health Risk |
Pathogenic |
— |
| RS2042451238 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2042451819 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS2042472129 |
QARS1
|
Health Risk |
Likely pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS2042480125 |
OCA2
|
Health Risk |
Likely pathogenic |
— |
| RS2042496890 |
DDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS2042497215 |
DDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, See cases |
| RS2042500119 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS2042510074 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS2042511461 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS2042518770 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS2042560955 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS2042561671 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2042562353 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2042570213 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, POLE-related polyposis and colorectal cancer syndrome |
| RS2042581336 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2042625844 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS2042626867 |
POLE
|
Health Risk |
Pathogenic |
— |